Inhibikase Therapeutics, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
Rok finansowy 2017 2017 2018 2018 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025
Kwartał Q1 Q4 Q1 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1
Data 2017-03-31 2017-12-31 2018-03-31 2018-12-31 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 0 1 1 1 1 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 138.9% -79.07% -82.00% -82.14% -54.19% 31.5% -69.72% 190.7% 419.7% 520.7% 771.7% -99.72% -96.73% -99.52% -100.00% 6249.8% 40.2% 1676.7% inf% -100.00% -100.00% -100.00% -100.00% -100.00% 0.0%
Marża brutto -3.85% 0.0% 15.3% 0.0% -163.20% -183.98% -104.91% -11.50% -4.55% -19.85% -219.98% 67.5% -72.82% -74.79% -860.41% -174295.99% -6454.26% -45415.61% 0.0% 95.9% 92.2% -36.76% 91.7% -656700.00% -inf% -inf% 0.0% 0.0% 0.0%
Koszty i Wydatki (mln) 0 1 1 3 2 2 1 0 1 0 1 1 3 3 4 5 5 5 5 4 5 6 5 4 5 5 6 13 15
EBIT (mln) -0 0 -0 -1 -2 -2 -1 -0 -1 -0 -1 -1 -3 -3 -4 -5 -5 -5 -5 -4 -5 -6 -5 -4 -5 -5 -6 -13 -15
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 866.4% -4437.83% 965.4% -66.46% -68.83% -82.30% -44.90% 184.4% 386.1% 535.0% 573.6% 319.8% 76.8% 76.5% 0.9% -14.01% 1.6% 33.7% 5.7% 1.6% 1.4% -18.57% 22.2% 193.6% 205.2%
EBIT (%) -72.48% 6.8% -16.36% -93.61% -293.12% -1400.95% -968.09% -175.74% -199.42% -188.50% -1761.44% -171.93% -186.56% -192.83% -1361.22% -259334.41% -10081.46% -70817.14% 0.0% -3511.81% -7307.62% -5328.07% -5993.38% -440357000.00% 0.0% 0.0% 0.0% nan nan
Przychody fiansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Amortyzacja (mln) 0 0 0 0 2 2 1 0 1 0 1 1 3 3 4 5 5 5 0 0 0 0 0 0 0 0 0 0 0
EBITDA (mln) 0 0 0 -1 -2 -2 -1 -0 -1 -0 -1 -1 -3 -3 -4 -5 -5 -5 -5 -4 -5 -6 -5 -4 -5 -5 -6 -13 -16
EBITDA(%) -2.57% 6.8% -1.72% -93.61% -293.12% -1400.95% -968.09% -175.74% -199.42% -188.50% -1761.44% -171.93% -186.56% -192.83% -1361.22% -259334.41% -10081.46% -70817.14% 0.0% -3522.74% -7299.80% -5191.30% -5985.11% -439700000.00% 0.0% 0.0% 0.0% nan nan
NOPLAT (mln) -0 0 -0 -1 -2 -2 -1 -0 -1 -0 -1 -1 -3 -3 -4 -5 -5 -5 -4 -4 -4 -6 -5 -4 -5 -5 -6 -12 -14
Podatek (mln) -0 0 -0 0 -2 -2 -1 -0 -1 -0 -1 -3 -3 -3 -4 -0 -5 -5 0 -0 -0 0 0 0 0 0 0 0 0
Zysk Netto (mln) -0 0 -0 -1 -2 -2 -1 -0 -1 -0 -1 -1 -3 -3 -4 -5 -5 -5 -4 -4 -4 -6 -5 -4 -5 -5 -6 -12 -14
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 835.3% -5352.33% 870.1% -66.00% -68.47% -82.00% -44.69% 180.9% 381.7% 524.9% 566.7% 317.4% 76.0% 76.0% 0.5% -17.34% -13.73% 24.5% 2.2% 0.3% 16.1% -14.16% 25.7% 190.4% 194.2%
Zysk netto (%) -75.05% 5.6% -18.08% -94.02% -293.75% -1404.30% -974.37% -178.97% -202.17% -192.12% -1779.72% -172.95% -187.40% -193.40% -1361.26% -259342.54% -10081.47% -70817.14% 0.0% -3375.91% -6204.86% -4963.46% -5775.11% -417794000.00% 0.0% 0.0% 0.0% nan nan
EPS -0.14 0.0259 -0.0962 -0.74 -1.27 -1.72 -0.89 -0.32 -0.4 -0.31 -0.49 -0.87 -1.57 -1.29 -1.07 -1.2 -1.1 -1.1 -1.06 -0.99 -0.87 -1.11 -0.86 -0.68 -0.73 -0.66 -0.65 -0.51 -0.15
EPS (rozwodnione) -0.14 0.0259 -0.0962 -0.74 -1.27 -1.72 -0.89 -0.32 -0.4 -0.31 -0.49 -0.87 -1.57 -1.29 -1.07 -1.2 -1.1 -1.1 -1.06 -0.99 -0.87 -1.11 -0.86 -0.68 -0.73 -0.66 -0.65 -0.51 -0.15
Ilośc akcji (mln) 1 2 1 2 1 1 1 1 1 1 1 1 2 2 4 4 4 4 4 4 5 5 5 6 6 8 9 24 90
Ważona ilośc akcji (mln) 1 2 1 2 1 1 1 1 1 1 1 1 2 2 4 4 4 4 4 4 5 5 5 6 6 8 9 24 90
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD